Professur für Kinder- und Jugendmedizin mit dem Schwerpunkt Pädiatrische Onkologie und Hämatologie

High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia (2019) Hoffmann J, Krumbholz M, Gutiérrez HP, Fillies M, Szymansky A, Bleckmann K, zur Stadt U, et al. Journal article Next-generation reference intervals for pediatric hematology (2019) Zierk J, Hirschmann J, Toddenroth D, Arzideh F, Haeckel R, Bertram A, Cario H, et al. Journal article TRIM28 haploinsufficiency predisposes to Wilms tumor (2019) Diets IJ, Hoyer J, Ekici AB, Popp B, Hoogerbrugge N, van Reijmersdal SV, Bhaskaran R, et al. Journal article Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Gruenewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma (2018) Machiela MJ, Gruenewald TG, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia (2018) Germeshausen M, Ancliff P, Estrada J, Metzler M, Ponstingl E, Ruetschle H, Schwabe D, et al. Journal article Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors (2018) Anderson ND, De Borja R, Young MD, Fuligni F, Rosic A, Roberts ND, Hajjar S, et al. Journal article Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial (2018) Kuhlen M, Bader P, Sauer M, Albert MH, Gruhn B, Gungor T, Kropshofer G, et al. Journal article Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients (2018) Suttorp M, Metzler M, Shimada H, Bansal D, Gunes AM, Kalwak K, Sedlacek P, et al. Journal article Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article